Aromatase Inhibition and Breast Cancer

"The goal of developing highly effective, well-tolerated, orally active aromatase inhibitors was set about 20 years ago after the recognition that inhibition of aromatase was the principal mode of action of the breast cancer drug aminoglutethimide (AG)."